Maxim Group

Vivian Cervantes joined Maxim Group LLC in February 2010 as Vice President and Senior Medical Device Analyst with broad knowledge and experience across subsectors, including: cardiovascular, orthopedic, wound management, women’s health, respiratory, and ophthalmology. Combined with nearly 10 years of financial analysis and investment experience at top investment banks, Cervantes also draws on early sector expertise in the technology and telecommunications industry to round out her analysis of medical device companies. Prior to joining Maxim, she held positions at Rodman & Renshaw, BMO Capital Markets, Merrill Lynch, and Morgan Stanley. Cervantes received her MBA from Columbia Business School and obtained her CPA designation following a BS degree in Accounting from Seton Hall University.